WASHINGTON, Jan. 20 -- Sen. Kirsten Gillibrand issued the following press release: Today, following years of continued advocacy, U.S. Senator Kirsten Gillibrand (D-NY) and Senate Democratic Leader Ch... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117171) titled 'The effect of remifentanil infusion on the incidence of postoperative c... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117179) titled 'A Study on the Association between Decision-making Difficulties, Anxiety S... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117114) titled 'Neural Mechanisms of Non-Suicidal Self-Injury Emotional Behavioral Disorde... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07355270) titled 'A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Eva... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07356323) titled 'A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07355296) titled 'PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescent... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07356245) titled 'Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07356284) titled 'Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Int... Read More
Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07356154) titled 'A Study of Revumenib and Mezigdomide in People With Leukemia' on Jan. 20. Stud... Read More